SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Lantern Pharma Names CFO David Margrave Interim CEO

Valid market news retained in the public archive without immediate LiveCast distribution.

LTRN

Related stories